← Eichor
Condition: Hepatobiliary Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatobiliary Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Li
Phase N/A · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07652892Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
Phase N/A · 1 location(s) · Steno Diabetes Center Copenhagen · NCT05890365Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians
Phase N/A · 1 location(s) · Novo Nordisk A/S · NCT07682363Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in
Phase N/A · 1 location(s) · Sohag University · NCT06953921Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NA · 2 location(s) · University of Pennsylvania · NCT06136221A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
Phase N/A · 10 location(s) · Astellas Gene Therapies · NCT06581146BeijngFH Health Cohort Study
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT05546086MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Phase N/A · 1 location(s) · University of Chicago · NCT05264051Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
Phase N/A · 1 location(s) · Mayo Clinic · NCT04232566Prevalence of NAFLD in T1DM Patients
NA · 1 location(s) · Ziekenhuis Oost-Limburg · NCT06445361Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
NA · 1 location(s) · Henry Ford Health System · NCT07646197Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
Phase N/A · 1 location(s) · Ningbo No. 1 Hospital · NCT06984510Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Phase 2 · 5 location(s) · Regeneron Pharmaceuticals · NCT07527910Lifestyle Modification in the Treatment of NAFLD.
NA · 1 location(s) · General University Hospital, Prague · NCT05816915LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT06989723Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome
Phase N/A · 10 location(s) · Fresenius Kabi · NCT06274788Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 2 location(s) · University Medical Center Groningen · NCT07585890Microplastics, Cirrhosis and Portal Hypertension
Phase N/A · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07280390Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Implementing Food Referrals for Equity and Sustained Health
Phase 2 · 2 location(s) · University of California, San Diego · NCT06661538Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease
NA · 1 location(s) · Uppsala University · NCT06701968NASH AMPK Exercise Dosing (AMPED) Trial
NA · 1 location(s) · Milton S. Hershey Medical Center · NCT04987879Efficacy and Safety of Rifaximin in Treating MAFLD
EARLY_Phase 1 · 1 location(s) · Shanghai Changzheng Hospital · NCT071859322D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07122622Corazones Unidos Study
NA · 1 location(s) · University of Arizona · NCT07298213Copper Supplementation in Cirrhosis
NA · 1 location(s) · University of Washington · NCT07471542
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.